Hyundai Pharmaceutical Co (XKRX:004310) Equity-to-Asset : 0.54 (As of Feb. 2024)

Hyundai Pharmaceutical Co Equity-to-Asset Chart

Hyundai Pharmaceutical Co Annual Data
	Trend	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22	Nov23
Equity-to-Asset		Get a 7-Day Free Trial					0.57	0.57	0.53	0.48	0.55

Hyundai Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Equity-to-Asset	Get a 7-Day Free Trial															0.48	0.54	0.55	0.55	0.54

Competitive Comparison of Hyundai Pharmaceutical Co's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Hyundai Pharmaceutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyundai Pharmaceutical Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hyundai Pharmaceutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Hyundai Pharmaceutical Co's Equity-to-Asset falls into.

Hyundai Pharmaceutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Hyundai Pharmaceutical Co's Equity to Asset Ratio for the fiscal year that ended in Nov. 2023 is calculated as

Hyundai Pharmaceutical Co's Equity to Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyundai Pharmaceutical Co  (XKRX:004310) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Hyundai Pharmaceutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Hyundai Pharmaceutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyundai Pharmaceutical Co (XKRX:004310) Business Description